The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Androgen pathway gene expression and response to hormonal therapy in prostate cancer (SWOG S1216).
 
Jacek Pinski
Stock and Other Ownership Interests - Vaxanix Bio
Speakers' Bureau - Astellas Oncology; AstraZeneca/Merck; Pfizer; Seagen; Sumitomo Pharma Oncology
 
Sue Ingles
No Relationships to Disclose
 
Zarko Manojlovic
No Relationships to Disclose
 
Shigang Xiong
No Relationships to Disclose
 
Daniel Weisenberger
No Relationships to Disclose
 
Amir Goldkorn
Research Funding - Menarini Silicon Biosystems; RareCyte; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor on a patent held jointly by USC and Caltech for a microfilter we developed for capturing live circulating tumor cells from blood.
 
David McConkey
Honoraria - H3 Biomedicine; Janssen Oncology
Consulting or Advisory Role - CG Oncology; Owkin
Research Funding - Convergent Genomics
 
Primo Lara
Consulting or Advisory Role - Genmab
Research Funding - AstraZeneca (Inst)
 
Maha Hussain
No Relationships to Disclose
 
David Quinn
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ian Thompson
Employment - CHRISTUS Health; CHRISTUS Health
Leadership - H-E-B (grocery store chain)
Consulting or Advisory Role - Magforce
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Seth Lerner
Stock and Other Ownership Interests - Aura Biosciences; C2i genomics
Honoraria - Grand Rounds in Urology; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; C2i Genomics; Ferring; Gilead Sciences; ImmunityBio; Incyte; Pfizer/EMD Serono; Protara Therapeutics; Stimit; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Aura Biosciences; Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; SURGE Therapeutics; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate
 
Tanya Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Hookipa Biotech (Inst); Janssen Oncology (Inst); Promontory Therapeutics (Inst)
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer